Ovoca Bio | OVG - Capital Ordinário





Capital Ordinário Alterar Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
ALKERMES USD 166.46M 855K 2026-03
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Great Western Mining Corporation EUR 177.19M 176.73M 2025-06
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Malin Corporation EUR 200K 0 2024-12
Moderna USD 391M 2M 2025-09
Organon & Co USD 260.32M 333K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Revvity USD 111.8M 1.57M 2026-03
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Viatris USD 1.16B 5.27M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12